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Summary
Objective: Chondrocyte-seeded tissue engineering scaffolds hold the promise of enhancing certain cartilage repair procedures. The objective
of this study was to evaluate the effects of selected growth factors [ﬁbroblast growth factor (FGF)-2 and insulin-like growth factor (IGF)-1]
individually and in combination on adult canine articular chondrocyte-seeded type II collageneglycosaminoglycan (GAG) scaffolds grown in
serum-free (SF) medium.
Design: Approximately 500,000 second passage chondrocytes were seeded into discs of the scaffold, 4 mm diameter! 2 mm thick. The
constructs were grown in the following media: serum-containing medium; a basal SF medium; SF with 5 ng/ml FGF-2; SF with 25 ng/ml FGF-2;
SF with 100 ng/ml IGF-1; and SF with 5 ng/ml FGF-2 plus 100 ng/ml IGF-1. The DNA and GAG contents of the scaffolds were determined after
1 day and 2 weeks and the protein and GAG synthesis rates determined at 2 weeks using radiolabels. Histology and type II collagen
immunohistochemistry were also performed.
Results: FGF-2 at 5 ng/ml was found to substantially increase the biosynthetic activity of the cells and the accumulation of GAG. The histology
demonstrated chondrocytes uniformly distributed through a matrix that stained intensely for GAG and type II collagen after only 2 weeks. Of
interest were the rapid degradation of the collagen scaffold, despite the fact that the scaffold was carbodiimide cross-linked, and the
contraction of the constructs. There were less pronounced effects using the higher dose of FGF-2 and the combination with IGF-1.
Conclusions: Chondrocyte-seeded type II collagen scaffolds cultured in SF medium supplemented with 5 ng/ml FGF-2 undergo contraction,
demonstrate an increase in construct incorporation of radiolabeled sulfate, and display qualitative signs of chondrogenesis.
Published by Elsevier Ltd on behalf of OsteoArthritis Research Society International.
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International
Cartilage
Repair
SocietyIntroduction
One tissue engineering approach being investigated for the
treatment of defects in articular cartilage involves the
implantation of autologous chondrocyte-seeded absorbable
scaffolds to facilitate regeneration in vivo. One of the many
critical parameters in the preparation of chondrocyte-
seeded scaffolds as implants for cartilage repair is the
culture conditions under which the constructs are grown. Of
particular interest are the supplements to the culture
medium: serum and growth factors. An array of growth
factors have been investigated for their potential to increase
cartilage repair1e7. Studies have evaluated the effects of
growth factors individually5,8,9 and in combination1,7,10 on
chondrocytes in monolayer and three-dimensional (3-D)
cultures. Insulin-like growth factor (IGF)-1 and ﬁbroblast
growth factor (FGF)-2 have been found to enhance the
activity of chondrocytes in vitro. IGF-1 was found to
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articular chondrocytes in a dose dependent manner. FGF-2
was shown to promote proliferation, glycosaminoglycan
(GAG) synthesis, and increase the differentiation capacity
of chondrocytes expanded in monolayer5,7,12. Other studies
have, however, demonstrated that FGF can inhibit chon-
drocyte differentiation13 and can have a catabolic effect on
cartilage explants11,14.
The objective of this study was to evaluate the effects of
IGF-1 and FGF-2 on second passage adult canine articular
chondrocytes grown in type II collageneGAG scaffolds.
Based on the prior studies demonstrating that these growth
factors promote proliferation and stimulate the biosynthetic
activity of chondrocytes5,7,11,12, our ﬁrst hypothesis was
that serum-free (SF) cultures supplemented with FGF-2 or
IGF-1 would result in a higher cell density, increased
biosynthetic activity, and increased quantity of matrix
produced by articular chondrocytes vs constructs cultured
in control media. Furthermore, we hypothesized (second
hypothesis) that a synergistic enhancement of matrix
synthesis would result from a combined supplementation
with IGF-1 and FGF-21,7. An SF medium without either of
these growth factors was employed as a control; the control
medium contained transforming growth factor-b1 (TGF-b)
and dexamethasone because these agents have been8
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taining medium without growth factor supplementation was
also employed for comparison.
In this study, we also evaluated the contraction of the
chondrocyte-seeded scaffolds in light of prior work that
suggested an association of chondrogenesis in tissue
engineering scaffolds and in cell pellets with a-smooth
muscle actin-enabled contraction16. The collageneGAG
scaffolds employed in the present work were carbodiimide
cross-linked and thus mechanically stiffer than those used
in previous work demonstrating chondrocyte contraction17.
A prior study demonstrated that collagen scaffold contrac-
ture decreased as the cross-link density increased18. This
led to a third hypothesis that there would be little contraction
(viz., less than 10% reduction in diameter) of the constructs
in the current work.
Materials and methods
COLLAGEN SCAFFOLDS
Porous type II collageneGAG matrices were employed in
this study. Sheets of the type II matrix, approximately 2.5 mm
thick, were fabricated by freeze drying a porcine cartilage-
derived slurry (Geistlich Biomaterials, Wolhusen, Switzer-
land). The matrices, prepared using a protocol similar to that
employed in this study, have been reported previously to
have a porosity of 89G 2% (meanG standard deviation)
and a pore diameter of 125G 42 mm19. A previous gel
electrophoresis analysis demonstrated that the collagen
slurries were comprised principally of type II collagen20.
The matrices were initially sterilized and cross-linked by
dehydrothermal treatment21. Four-millimeter-diameter disks
were cut from the sheets and additionally cross-linked by
carbodiimide treatment18; the matrices were immersed in
a solution comprising 14 mM 1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide hydrochloride (EDAC) and 5.5 mM N-
hydroxysuccinimide (Sigma Chemical Co., St. Louis , MO)
for 2 h at room temperature. Through a series of sterile
washes, ﬁrst with phosphate-buffered saline (PBS) followed
by two washes with distilled water, excess EDAC was
removed from the type II matrices. The mechanical
properties of EDAC-treated collageneGAG matrices have
been reported previously18.
CELL ISOLATION AND CULTURE
Chondrocytes were isolated from the trochleae of the
adult canine knees (stiﬂe joints) from one adult mongrel
dog. The cells were obtained using a sequential digestion of
pronase (20 U/ml, 1 h) and collagenase (200 U/ml, over-
night) as previously described22. Once the chondrocytes
were isolated, they were suspended in the control medium
adapted from Jakob et al.7. Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco Life Technologies, Carlsbad,
CA) supplemented with 10% fetal bovine serum (FBS,
Hyclone Technologies, Logan, UT), 4.5 mg/ml D-glucose,
0.1 mM nonessential amino acids, 1 mM sodium pyruvate,
100 mM N-2-Hydroxyethylpiperazine-N#-2-ethanesulfonic
acid (HEPES) buffer, 100 U/ml penicillin, 100 mg/ml strep-
tomycin, and 0.29 mg/ml L-glutamine. Chondrocytes were
plated in 75-cm2 ﬂasks at 2 million cells/ﬂask. The cells
were incubated at 37(C and 5% CO2. During monolayer
expansion, the control medium was supplemented
with 1 ng/ml TGF-b, 5 ng/ml FGF-2, and 10 ng/ml platelet-
derived growth factor-bb (all from R&D Systems,Minneapolis, MN). Once cells reached conﬂuence, they
were trypsinized, resuspended and replated into 75-cm2
ﬂasks using 2 million cells/ﬂask.
CELL SEEDING AND CULTURE OF COLLAGEN MATRICES
Chondrocytes expanded through two (P2) passages
were seeded into the porous type II collagen scaffolds.
Each cell suspension consisted of 7.5! 106 cells/ml in
each respective medium to be investigated (see below,
Groups AeF). Fifteen scaffold samples for each seeding
run were incubated in 1 ml of the suspension for 1.5e2 h on
a nutator (Lab Quake Shaker, Cat. #T400-110, Labindus-
tries, Inc., Berkeley, CA); the nutator was set at 360(
rotation. By this ‘‘dynamic seeding’’ method approximately
50% of the chondrocytes attach to the matrices, providing
a cell number density approximating that of articular
cartilage (10,000 cells/mm3)23.
The cell-seeded scaffolds were cultured in one of the
following six media:
A. Standard culture medium (DMEM/F12, Gibco) supple-
mented with 10% FBS (Hyclone Technologies),
25 mg/ml ascorbic acid 2-phosphate (Wako Chemical,
Osaka, Japan), and penicillin/streptomycin/Fungizone
cocktail (Gibco);
B. SF medium adapted from Jakob et al.7, which
consisted of DMEM supplemented with ITSC1 (insulin,
transferrin, sodium selenite; Sigma Chemical, St.
Louis, MO), 0.1 mM ascorbic acid 2-phosphate, and
1.25 mg/ml bovine serum albumin, 10 ng/ml TGF-b,
and 107 M dexamethasone;
C. SF supplemented with 5 ng/ml FGF-2 (R&D Systems);
D. SF supplemented with 25 ng/ml FGF-2;
E. SF supplemented with 100 ng/ml IGF-1 (R&D Sys-
tems); or
F. SF supplemented with 100 ng/ml IGF-1 and 5 ng/ml
FGF-2.
The cell-seeded matrices were ﬁrst incubated overnight
in 0.5 ml of group speciﬁc medium per well on agarose-
coated wells (24-well plates). The following day, 0.5 ml was
added to each well to provide a volume of about 1 ml. Media
(1 ml) were changed every other day. Cultures were
terminated at 1 day and 2 weeks. Non-cell-seeded matrices
were cultured as controls.
CHONDROCYTE-MEDIATED CONTRACTION
The diameters of cell-seeded and non-seeded matrices
were measured 1 day and 1 and 2 weeks post-seeding
(nZ 6). Chondrocyte-mediated contraction (CMC) was
determined by subtracting the percentage contraction of
non-seeded constructs from the percentage change in the
diameters of cell-seeded constructs.
DNA ANALYSIS
The DNA content of the matrices (nZ 6) was measured
using the Hoechst 33258 dye method24. A 50 ml aliquot of
a proteinase K digest (see RADIOLABEL INCORPORA-
TION below) mixed with 2 ml of Hoechst dye solution (10%
Hoechst dye in 10 mM Tris, 1 mM Na2EDTA (ethylenedia-
minetetraacetic acid) and 0.1 M NaCl, pH 7.4) was assayed
ﬂuorometrically. The results were extrapolated from a stan-
dard curve established using calf thymus DNA. The
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by subtracting the values of the non-seeded matrices.
GAG ANALYSIS
The GAG content of the matrices (nZ 6) was determined
by the dimethylmethylene blue (DMMB) dye assay25. A
100 ml aliquot of the proteinase K digest was mixed with
2 ml of the DMMB dye and the absorbance at 525 nm was
measured with a spectrophotometer. The results were
obtained by extrapolating from a standard curve using shark
chondroitin-6-sulfate. The newly accumulated GAG was
determined by subtracting the non-seeded values from the
sample values.
RADIOLABEL INCORPORATION
At week 2, P2 cell-seeded matrices of the type II scaffolds
(nZ 6) were incubated in medium containing 5 mCi/ml each
of 3H-proline and 35S-sulfate to determine total protein and
GAG synthesis, respectively. At the end of the 24-h
radiolabeling period, the matrices were washed
(5! 15 min at 4(C) in PBS supplemented with unlabeled
proline (100 mM) and sulfate (500 mM). The scaffolds were
lyophilized and solubilized overnight at 60(C with 1 ml of
proteinase K solution (100 mg in 1 ml 50 mM TriseHCl
buffer with 1 mM CaCl2). In order to determine the
radioactivity content, 100 ml aliquots of the digest were
mixed with 4 ml scintillation ﬂuid (ScintiVerse II; Fisher
Scientiﬁc Co.) and counted in a liquid scintillation counter
(Packard Tri-Carb 1600 TR; Packard Instrument Co.). The
3H and 35S counts per minute (cpm) were recorded with
corrections for spillover, and then converted to nanomoles
of incorporated radiolabel. Counts were normalized to
incorporation time and DNA content.
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATION
After ﬁxation in 10% neutral-buffered formalin, the speci-
mens (nZ 3) were rinsed in PBS, dehydrated, and
embedded in parafﬁn. Specimens were sectioned into
5-mm-thick sections and mounted on glass slides for
staining with hematoxylin and eosin for determination of
cell distribution and morphology and Safranin O and fast
green staining for GAG.
Type II collagen immunohistochemistry was performed
using a mouse anti-chick monoclonal antibody for type II
collagen (obtained from the Developmental Studies Hybrid-
oma Bank, Iowa City, IA). A standard avidinebiotin complex
peroxidase-based antibody staining technique (Vectastain,
Vector Laboratories, Burlingame, CA) was employed.
Sections were enzymatically digested by protease type
XIV for 45 min prior to the staining.
STATISTICAL ANALYSIS
Data from one animal was pooled and is reported as the
meanG standard error of the mean (S.E.M.) One-factor and
two-factor analyses of variance (ANOVAs) and Fisher’s
protected least square differences (PLSD) post-hoc testing
were performedusingStatView (SAS Institute Inc,Cary, NC).
Results
MATRIX CONTRACTION
The CMC for the type II collagen seeded matrices over
the 2-week period was affected by culture medium (Fig. 1).Chondrocyte-seeded scaffolds cultured in medium contain-
ing FBS demonstrated less than about 5% CMC (Group A
in Fig. 1). This result is in accordance with previous studies
performed with serum-supplemented expansion and culture
medium for EDAC-cross-linked matrices18. There was
slightly more contraction of the cell-seeded scaffolds
cultured in the SF medium (Group B in Fig. 1), but still
less than 10%. In contrast, the culture groups using SF
media with FGF-2 and IGF-1 (Groups CeF in Fig. 1)
resulted in CMC up to 60%. Two-factor ANOVA revealed
a signiﬁcant effect of time (P! 0.02; powerZ 0.72) and
culture medium (FBS vs SF media; P! 0.0001; powerZ 1)
on CMC. The similarity of the ﬁndings after 1 and 2 weeks,
despite the statistically signiﬁcant ANOVA result, would
suggest that the effect of time on CMC is not likely very
meaningful.
DNA CONTENT OF THE MATRICES
The number of cells adherent to the type II collagen
matrices after 1 day in culture, reﬂected in the DNA content,
varied by a factor of about 2 dependent upon the culture
medium (Fig. 2). The basal SF medium had the lowest DNA
content at 1 day and the medium with serum the highest
(Fig. 2). Depending on the value used for the amount of
DNA per chondrocyte, the number of cells in the scaffold
ranges around 260,000 (2 mg of DNA divided by 7.7 pg
DNA/chondrocyte24) or 50% of the number of cells per
scaffold used in the dynamic seeding; others have found
8 pg DNA/cell for fetal bovine26 and 11.6 pg/cell for
human27 chondrocytes. From day 1 to 2 weeks there was
a substantial increase in the cell number (from 2- to 3-fold)
in the FBS group (A), the group in SF plus 5 ng/ml FGF-2
(C), and the group with the FGF and IGF (F).
Two-factor ANOVA demonstrated that the type of medium
and the time in culture had statistically signiﬁcant effects on
the DNA content of the scaffolds (both P! 0.0001;
powerZ 1). Fisher’s PLSD post-hoc testing showed
that there was no statistically signiﬁcant difference among
the three groups with the highest DNA values: cultures in
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Fig. 1. Cell-mediated contraction. The samples cultured in the SF
media contracted substantially more than the specimens on the
media containing serum. A. medium supplemented with FBS; B.
SF basal medium; C. SF with 5 ng/ml FGF-2; D. SF with 25 ng/ml
FGF-2; E. SF with 100 ng/ml IGF-1; and F. SF with 100 ng/ml IGF-1
and 5 ng/ml FGF-2. Error bars represent S.E.M. and nZ 6.
281Osteoarthritis and Cartilage Vol. 13, No. 4FBS (A), SF plus 5 ng/ml FGF-2 (C), and the group with
FGF and IGF (F). These three elevated groups were
signiﬁcantly different by post-hoc testing from the other
groups (all with P! 0.0001). The scaffolds cultured in the
basal SF medium displayed signiﬁcantly less DNA than the
other groups at 1 day and 2 weeks (P! 0.0001).
RADIOLABEL INCORPORATION
The following rates of radiolabel incorporation apply to
the newly synthesized protein and GAG that were bound to
the scaffold. Newly synthesized molecules lost to the
medium were not captured in this analysis. Because the
ultimate goal is the production of a cell-seeded scaffold for
implantation, the focus of the work is the molecular make-up
of the cell-seeded construct.
The cells seeded in the type II collagen matrices
exhibited protein biosynthetic activity at the 2-week labeling
point for all groups. The FGF-supplemented SF media
groups (Groups C and D) demonstrated the highest rates of
proline incorporation [Fig. 3(a)]; there was no increase in
proline incorporation with increasing FGF-2 dose from 5 to
25 ng/ml. Of interest was that the scaffolds cultured in
a combination of IGF and FGF (Group F) displayed less
than half the protein synthetic rate of the scaffolds cultured
in the FGF alone [Groups C and D; Fig. 3(a)]. The lower
proline incorporation rate of the combined group (F) was at
the level of the scaffolds cultured in the IGF alone (Group
E). One-factor ANOVA revealed a signiﬁcant effect of
culture medium type on the proline incorporation (P! 0.03;
powerZ 0.79). Post-hoc testing showed that the proline
incorporation by the cells in the FGF-supplemented media
(Groups C and D) were statistically signiﬁcantly higher than
the IGF-supplemented groups (E and F).
There were low sulfate incorporation rates for the
chondrocyte-seeded scaffolds cultured in serum or in the
basal SF medium [Groups A and B in Fig. 3(b)]. Supple-
mentation of the SF medium with 5 ng/ml resulted in a 4-fold
increase in sulfate incorporation (i.e., comparing Groups B
and C). Of interest was the ﬁnding that the sulfate
incorporation rate dropped when the FGF-2 concentration
was increased from 5 to 25 ng/ml. Addition of IGF to the SF
basal medium led to a 2-fold increase in the sulfate
incorporation (comparing Groups E and F). Combining
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Fig. 2. DNA content of seeded type II CG matrices. Total DNA
content of proteinase K digests of seeded type II collageneGAG
matrices minus DNA content of non-seeded matrices to account
for background ﬂuorescence. Error bars represent S.E.M. and
nZ 6.5 ng/ml of FGF-2 with the IGF doubled the incorporation
rate almost bringing it to the level of the SF medium
supplemented with the 5 ng/ml alone [Group C in Fig. 3(b)].
One-factor ANOVA revealed a signiﬁcant effect of medium
on sulfate incorporation (P! 0.0001; powerZ 1.00). Fish-
er’s PLSD testing demonstrated that there was no
statistically signiﬁcant difference between the two groups
with in serum containing 5 ng/ml of FGF-2 (i.e., Groups C
and F).
GAG CONTENT OF THE MATRICES
The GAG content of the cell-seeded scaffolds after 1 day
was low, the amount generally reﬂecting the initial GAG
content (Fig. 4). There was a substantial increase in the
GAG content of the chondrocyte-seeded scaffolds after 2
weeks with the values seen in the sample cultures in media
containing 5 ng/ml FGF-2, as was seen with the sulfate
incorporation data. There was a 5-fold increase in the
amount of GAG when 5 ng/ml was added to the SF basal
medium (comparing Groups B and C). The lower GAG
content of the scaffolds cultured in the higher FGF-2
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Fig. 3. Radiolabel incorporation. Newly synthesized (a) total protein
measured by 3H-proline and (b) GAG measure by 35S-sulfate
incorporation in the type II collageneGAG matrices. Amount of
radiolabel incorporated into the matrices was normalized to the
period of radiolabel administration and DNA content. Error bars
represent S.E.M. and nZ 6.
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5 ng/ml data, also paralleled the sulfate incorporation
ﬁndings. Addition of IGF to the SF medium increased the
GAG content about 2-fold (comparing Groups B and E).
Combining 5 ng/ml FGF-2 with the IGF more than tripled the
GAG content (Groups E and F in Fig. 4).
One-factor ANOVA at 2 weeks revealed a signiﬁcant
effect of culture medium on the GAG content of the matrices
(P! 0.0001; powerZ 1). Post-hoc testing showed that
there was no statistically signiﬁcant difference between the
serum (A) and basal SF (B) groups or between the groups
with 5 ng/ml FGF-2 (C) and the combined growth factor (F)
group.
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
OF CELL-SEEDED MATRICES
Cell density and the distribution of chondrocytes through-
out the scaffolds varied among groups, as demonstrated
through hematoxylin and eosin staining. There was
a dramatic difference in the histologic appearance of the
chondrocyte-seeded scaffold cultured in the SF medium
supplemented with 5 ng/ml [Group C; Fig. 5(a)] when
compared with the serum control [Group A; Fig. 5(b)]. In
Group C, cells were uniformly distributed throughout the
entire scaffold with few remnants of residual collageneGAG
scaffold visible. A majority of the cells in the scaffolds
cultured in 5 ng/ml FGF-2 were of rounded, chondrocytic
morphology, and displayed distinct lacunae (which were
more evident in the Safranin O-stained sections below). In
contrast, histologic sections of the specimens from Group A
demonstrated the presence of the collageneGAG scaffolds
in near intact form [Fig. 5(b)]. Qualitatively, examination of
the histological sections indicated that most cells were
distributed around the perimeter of the scaffold. Cells in the
internal pores were generally seen on the walls of the
scaffold and there was generally not much noticeable newly
synthesized matrix ﬁlling the pores [Fig. 5(b)]. Cells in the
Group A scaffolds also displayed a rounded morphology
[Fig. 5(b)].
The Safranin O-stained sections of the chondrocyte-
seeded scaffolds cultured in the 5-ng/ml-supplemented SF
medium displayed vibrant red staining of GAG throughout
the entire construct [Fig. 6(a)]. The lacunae surrounding
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Fig. 4. GAG content of seeded type II CG matrices. Net GAG
accumulation (total GAG minus GAG originally in non-cell-seeded
matrices) of proteinase K digests of seeded type II collageneGAG
matrices. Error bars represent S.E.M. and nZ 6.most cells were revealed as they stained less strongly for
GAG than the interterritorial matrix. The cells near the
surface of the constructs were of a more ﬂattened and
elongated morphology and densely aggregated [Fig. 6(a)].
There was little staining of GAG in the periphery of the
constructs [Fig. 6(a)]. The few remnants of the original
scaffold remaining after 2 weeks were more evident in the
Safranin O-stained sections [arrows in Fig. 6(a)] than in the
sections stained with hematoxylin and eosin. In contrast to
the Group C samples, the FBS-supplemented group
showed only light Safranin O staining in the pericellular
matrix and around the periphery of the scaffold [Fig. 6(b)].
Type II collagen revealed by immunostaining was most
pronounced in the samples cultured in 5 ng/ml of FGF-2
[Group C; Fig. 7(a)]. Chondrocytes seeded in the type II
collagen matrices for up to 2 weeks were found to
synthesize and deposit type II collagen in the scaffolds of
Groups A, CeF, but there was substantially less type II
collagen [e.g., Group A in Fig. 7(b)]. For Group C
specimens [Fig. 7(a)], the distribution type II collagen
throughout the construct paralleled the proteoglycan stain-
ing [Fig. 6(a)]. The lacunae were evident in the type II
immunohistochemical sections [Fig. 7(a)] as they were in
the Safranin O-stained material.
Fig. 5. Light micrographs of articular canine chondrocytes seeded
in type II collagen matrices cultured in (a) 5 ng/ml of FGF-2 (Group
C) and (b) 10% FBS (Group A) sacriﬁced at 2 weeks. Hematoxylin
and eosin; scale barZ 50 mm.
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A striking ﬁnding of this study was the dramatic effect of
5 ng/ml FGF-2 on the matrix production of chondrocytes in
a type II collageneGAG scaffold after 2 weeks and their
remodeling of the scaffold. The histology and immunohis-
tochemistry of these constructs demonstrated a mature
tissue comprising proteoglycan and type II collagen with
uniformly dispersed cells of chondrocytic morphology in
lacunae. The biochemical ﬁndings at 2 weeks were
consistent with the histology in that they showed the
chondrocyte-seeded scaffolds grown in the SF medium
with 5 ng/ml FGF-2 had the highest cell numbers, highest
rates of protein and sulfate incorporation, and the highest
GAG content. These results conﬁrmed the hypothesis that
culture of chondrocyte-seeded collagen scaffolds in SF
medium supplemented with FGF-2 results in a higher cell
density and increased biosynthetic activity. At the same
time, the hypothesis that there would be a synergistic effect
of FGF-2 and IGF-1 was not supported. The combination of
5 ng/ml and 100 ng/ml of IGF-1 did not result in elevated
levels of GAG or biosynthetic activity above the values for
Fig. 6. Light micrographs of articular canine chondrocytes seeded
in type II collagen matrices cultured in (a) 5 ng/ml of FGF-2 (Group
C) and (b) 10% FBS (Group A) sacriﬁced at 2 weeks. Arrows in (a)
show fragments of the original collageneGAG scaffold. The tears in
the histological sections which were seen bordering the residual
fragments occurred during microtomy. Safranin O/fast green; scale
barZ 100 mm. the FGF-2 alone and in the case of proline incorporation
rate led to a decrease. One of the limitations of the study
was the use of cells from only one animal. Future work will
be necessary to assess the individual-to-individual variabil-
ity in the ﬁndings.
Another notable ﬁnding was the dramatic contraction of
the growth factor-supplemented groups compared to the
10% FBS cultured group. For Group A (10% FBS), the
EDAC cross-linking imparted a sufﬁcient degree of me-
chanical stiffness to resist the amount of CMC which was
expected for a type II collageneGAG scaffolds cultured in
10% FBS based on prior work18. An unexpected result,
negating our third hypothesis, was the dramatic contraction
of matrices cultured in the SF environments supplemented
with various growth factors. The groups with SF base media
exhibited up to 50% more contraction than the serum-
containing control. The reduction in diameter of the
scaffolds was likely due to a combination of cell-mediated
contraction demonstrated in prior work to be related to the
expression of a-smooth muscle actin by the cells17 and
degradation of the scaffold. The elongated cells at the
periphery of the samples were similar to those described as
being the likely agents of the circumferential contractile
forces causing the contracture of the specimens16,17. The
histological ﬁnding of little residual scaffold material after 2
Fig. 7. Light micrographs of articular canine chondrocytes seeded
in type II collagen matrices cultured in (a) 5 ng/ml of FGF-2 (Group
C) and (b) 10% FBS (Group A) sacriﬁced at 2 weeks. Type II
collagen Immunohistochemistry; scale barZ 50 mm.
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enzymatic activity resulted in degradation of the scaffolds
making them more susceptible to cell-mediated contraction.
Moreover, the degradation of the scaffold material com-
mensurate with formation of matrix may be representative of
a remodeling process. The difﬁculty in quantifying the
amount of residual scaffold and in assaying for enzymatic
activity precluded detailed analyses in the current work. It
would be of interest in future studies to attempt quantiﬁca-
tion of these variables.
The ﬁnding that the adoption of a chondrocytic morphol-
ogy by the cells and their synthesis of cartilage matrix
paralleled cell-mediated contraction of the scaffolds would
seem to support the supposition that there may be an
association between contraction of the chondrocyte-seeded
constructs and chondrogenesis, as has been previously
proposed16. It was suggested that contraction of a centri-
fuged pellet of chondrocytes e a frequently used chondro-
genic assay15 e or a chondrocyte-seeded scaffold may be
a determinant of cartilage differentiation as a result of (1)
better containing newly synthesized matrix molecules or (2)
a linked signaling effect on the biosynthetic activity of the
cells16. Moreover, contraction may have favored chondro-
genesis by increasing chondrocyte density and cell-to-cell
contacts. While the cell density (viz., number of cells per
unit area) was not evaluated in the current work, it was clear
qualitatively that the constructs with the greater degree of
contraction (Group C vs Group A) displayed higher cell
densities throughout the scaffolds (Figs. 5e7). These
hypotheses, relating contraction to chondrogenesis, need
to be tested in future studies.
In light of the above, the possibility presents itself of
employing contraction as a method of regulating chondro-
genesis in cell-seeded constructs. Scaffolds could be
prepared in sizes larger than the required implant dimen-
sions. Cell-medicated contraction would bring the con-
structs to the required size. In the present investigation
a starting 4-mm diameter disk of the scaffold was reduced in
diameter to 2 mm. In the future the initial size of the scaffold
could be selected so that the ﬁnal contracted size would be
suitable for implantation into a cartilage defect; rather than
growing a construct to the required dimensions the cell-
seeded scaffold would be contracted to the required ﬁnal
dimensions. One challenge of such an approach is whether
such a contraction process is controllable given that its
mechanism is not fully understood. As noted above,
contraction of chondrocyte-seeded scaffolds has been
associated with the cell expression of a-smooth muscle
actin, and this expression has been found to be stimulated
by selected growth factors including TGF-b17. This raises
the possibility of selectively controlling the contractile
process through the use of certain growth factors. Another
important issue that would have to be dealt with is the
number of cells that would initially be required per scaffold
such that the desired cell density would be achieved after
contraction.
The ideal composition of a cell-seeded scaffold intended
to be used as an implant to facilitate regeneration in vivo
has yet to be determined; the objective is not to form
articular cartilage in vitro but rather to have the implant
induce the process in vivo and to be remodeled (i.e.,
resorbed and replaced by articular cartilage) in the process.
In this approach, a construct that displays even less
cartilaginous matrix than that in the Group C specimens in
the present work might be suitable for implantation. The
most suitable compositions of cell-seeded constructs for
regeneration in vivo will have to be resolved in future animalinvestigations and human trials. Until this critical issue is
resolved, the meaningfulness of comparing the composition
of constructs prepared using different scaffolds and culture
conditions is limited. Moreover, such comparisons are
confounded by the differences in the composition, degra-
dation rate, and mechanical properties of the scaffold
materials, as these can have effects on the mass of the
scaffolds, and composition (e.g., for GAG-containing scaf-
folds) and mechanical behavior of the constructs. This point
notwithstanding future studies need to be directed to
document selected properties including the GAG content
normalized to wet and dry weight for comparison with other
studies. While direct comparisons of cell-seeded constructs
are challenging, it is possible to begin to get a more
complete view of the effects of selected growth factors on
chondrocyte-seeded scaffolds.
FGF-2 has been shown to promote proliferation and GAG
synthesis of chondrocytes in monolayer12 as well as to
increase the differentiation capacity of articular chondro-
cytes in monolayer culture5. In a more recent study, FGF-2
has also been shown to not only enhance cell proliferation
and differentiation during expansion, but also promote the
chondrocyte potential to redifferentiate and respond to
growth factors upon transfer to a 3-D culture environment7.
The results of the current work support the prior ﬁndings
that 5 ng/ml FGF-2 enhanced GAG synthesis in calf
chondrocyte-seeded polyglycolic acid scaffolds5. Of interest
in related prior work4 was the ﬁnding that FGF-2 reduced
the contraction seen in calf chondrocyte-seeded polygly-
colic acid scaffolds. It was proposed that this effect was
explained by reduced expression of a-smooth muscle actin
by the cells and the accumulation of newly synthesized
matrix molecules. The ﬁnding in the present study that
specimens cultured in FGF-2-supplemented medium con-
tracted may be explained by the effects of this cytokine in
increasing the enzymatic activity of the cells and their
breakdown of the collageneGAG scaffold making the
construct more susceptible to cell-mediated contraction.
The fact that the current study found a decrease in the
effects of FGF-2 when the dose was increased from 5 to
25 ng/ml is consistent with previous investigations that
found that the maximal effects occurred in the range of
1e10 ng/ml12,13.
IGF-1 has been shown in past work to stimulate pro-
liferation and extracellular matrix biosynthesis both in vivo by
chondrocytes and in vitro by chondrocytes or cartilage
explants10,11,28,29. In the present study, while IGF-1
also stimulated matrix synthesis, it did not reach the levels
induced by FGF-2. For the group supplemented with 5 ng/ml
FGF-2 and 100 ng/ml IGF-1, there was not even an additive
effect on biosynthesis, DNA content, or GAG accumulation.
Other studies have observed a synergistic effect using
multiple growth factors in culture1,7,30, but in all cases the
synergism was not observed for all assays performed. A
study by Fu et al.,30 found a synergistic reaction using IGF-1
and FGF-2 on cell proliferation of rabbit chondrocytes, but
the culture was only prolonged for a maximum of 3 days30.
These ﬁndings commend the further investigation of SF
medium supplemented with 5 ng/ml FGF-2 for the prepara-
tion of chondrocyte-seeded type II collagen scaffolds for
cartilage repair. In the present study, FGF-2 supplemented
SF culture medium was associated with contraction of
chondrocyte-seeded scaffolds, an increase in construct
incorporation of radiolabeled sulfate, and qualitative signs
of chondrogenesis. A comparable type II collagen scaffold
has been shown to favor certain chondrogenic processes in
prior reports of in vitro31,32 and in vivo33,34 studies. The
285Osteoarthritis and Cartilage Vol. 13, No. 4ﬁndings favoring the growth of chondrocytes in type II
collagen scaffolds were supported by other investigations
that demonstrated a more favorable response of chondro-
cytes grown on type II collagen substrates to selected
growth factors when compared to chondrocytes grown on
type I collagen35,36. Comparisons between the results of the
current work with the type II collagen scaffold and prior
studies with type II collagen are, however, limited by the
effects of other experimental conditions on the results.
While the use of the type II collagen scaffolds along with
selected growth factors for producing constructs for
implantation is promising, it will be of importance in future
work to determine what adjustments in the preparation of
the cell-seeded scaffolds are necessary when employing
larger scaffolds for the preparation of larger implants for
cartilage repair procedures.
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